Get the Stockscreener App
0.70
1.27%
-0.009
After Hours:
.74
0.04
+5.71%
Vor Biopharma Inc stock is traded at $0.70, with a volume of 639.28K.
It is down -1.27% in the last 24 hours and down -19.93% over the past month.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
See More
Previous Close:
$0.709
Open:
$0.63
24h Volume:
639.28K
Relative Volume:
0.77
Market Cap:
$48.57M
Revenue:
-
Net Income/Loss:
$-115.51M
P/E Ratio:
-0.3448
EPS:
-2.03
Net Cash Flow:
$-95.89M
1W Performance:
-15.66%
1M Performance:
-19.93%
6M Performance:
-70.46%
1Y Performance:
-66.98%
1-Day Range:
$0.63
$0.762
1-Week Range:
$0.63
$0.85
52-Week Range:
$0.63
$3.1399
Vor Biopharma Inc Stock (VOR) Company Profile
Name
Vor Biopharma Inc
Sector
Industry
Phone
617-655-6580
Address
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-26-22 | Initiated | Wedbush | Outperform |
| Apr-27-22 | Initiated | Goldman | Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
| Dec-03-21 | Initiated | Robert W. Baird | Outperform |
| Dec-02-21 | Initiated | Oppenheimer | Outperform |
| Oct-19-21 | Initiated | JMP Securities | Mkt Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Mar-03-21 | Initiated | Evercore ISI | Outperform |
| Mar-02-21 | Initiated | Goldman | Sell |
| Mar-02-21 | Initiated | Stifel | Buy |
View All
Vor Biopharma Inc Stock (VOR) Latest News
Vor Biopharma Inc (VOR) deserves closer scrutiny - US Post News
Vor Biopharma Inc. Appoints Han Choi as Chief Financial Officer - Marketscreener.com
Metric Analysis: Vor Biopharma Inc (VOR)’s Key Ratios in the Limelight - The Dwinnex
Vor Biopharma Appoints New CFO, Enhances Leadership Team - TipRanks
Vor Biopharma (VOR) Appoints Han Choi as CFO - StreetInsider.com
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer - GlobeNewswire
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer - GlobeNewswire Inc.
Vor Biopharma stock plunges to 52-week low of $0.69 - Investing.com
Potential Price Increase for Vor Biopharma Inc (VOR) After Recent Insider Activity - Knox Daily
VOR’s Stock Market Adventure: -65.78% YTD Growth Amidst Volatility - The InvestChronicle
Investing in Vor Biopharma Inc (VOR) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
VHS BEYOND Movie - One News Page
Vornado Realty Trust stock outperforms competitors on strong trading day - MarketWatch
Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily
Vapotherm director James Liken sells $15,956 in stock, disposes of additional $119,481 worth - Investing.com
Shudder Streaming Seventh ‘V/H/S’ Horror Movie Franchise Release on Oct. 4 - Media Play News
Rev Up Your Chainsaw and Sit Down to Watch this V/H/S/Beyond Trailer - Reactor
V/H/S Beyond Archives - Media Play News
Found Footage Frights Abound in Official Trailer for V/H/S/BEYOND - Daily Dead
‘V/H/S/BEYOND’ Shows Off Sci-Fi Anthology Terror In New Trailer - That Hashtag Show
V/H/S Prepares You for Insanity with This Brand New Trailer - iHorror Movie News
V/H/S/BEYOND Trailer Unleashed For Halloween Season - Starburst Magazine
Horror meets sci-fi in V/H/S/Beyond trailer as early reviews call it the "strongest collection of tales in V/H/S history" - Gamesradar
The Gore-Soaked V/H/S/Beyond Trailer Teases The Best Entry In The Long-Running Horror Franchise - imdb
V/H/S/BEYOND Official Trailer: Lots of Horror Action And Cosmic Gore in Store For Franchise Fans - ScreenAnarchy
‘V/H/S/BEYOND’ Trailer: The 7th ‘V/H/S’ Entry Arrives On Shudder In October - The Playlist
V/H/S/Beyond gets a new trailer - Live for Films
V/H/S/BEYOND Trailer Delivers Sci-Fi Horror Footage with Lots of Gore - Nerdist
'V/H/S/BEYOND' trailer teases genuinely stomach-churning found footage horror - Mashable
The Gore-Soaked V/H/S/Beyond Trailer Teases The Best Entry In The Long-Running Horror Franchise - SlashFilm
Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.83, Down -7.78 - The Dwinnex
Lombard Odier Asset Management USA Corp Has $236,000 Stock Position in V2X, Inc. (NYSE:VVX) - MarketBeat
Inspire Investing LLC Decreases Stock Position in Varonis Systems, Inc. (NASDAQ:VRNS) - Defense World
Ventyx stock climbs 8% on $27M Sanofi investment - MSN
Hood River Capital Management LLC Lowers Holdings in Varonis Systems, Inc. (NASDAQ:VRNS) - Defense World
Westwood Holdings Group Inc. Has $41.52 Million Stock Holdings in Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Vor Biopharma Inc. (NYSE:VOR) Shares Acquired by Acadian Asset Management LLC - Defense World
V/H/S/Beyond Review: An Out Of This World Horror Anthology [Fantastic Fest] - SlashFilm
Victory Capital Management Inc. Increases Stock Position in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences director sells shares worth over $228k - Investing.com
Seven Eight Capital LP Acquires 4,077 Shares of Veralto Co. (NYSE:VLTO) - Defense World
VOXX International (NASDAQ:VOXX) Share Price Crosses Above Two Hundred Day Moving Average of $4.98 - MarketBeat
Vornado Realty Trust stock rises Thursday, still underperforms market - MarketWatch
VRNA Stock Sees Decline of Approximately -3.05% in Last Five Days - Knox Daily
Resolute Capital Asset Partners LLC Invests $723,000 in Verona Pharma plc (NASDAQ:VRNA) - Defense World
Vor Biopharma : CRISPR-Based Therapy Analytical Development Summit – Oral Presentation - Marketscreener.com
Veralto Co. (NYSE:VLTO) Shares Sold by Brown Brothers Harriman & Co. - Defense World
Resolute Capital Asset Partners LLC Takes $723,000 Position in Verona Pharma plc (NASDAQ:VRNA) - MarketBeat
Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.93, Down -2.48 - The Dwinnex
Vor Biopharma Inc (VOR) requires closer examination - US Post News
Vornado Realty Trust (VNO) may enjoy gains as insiders got busy in the recent days - Knox Daily
Vor Biopharma Inc Stock (VOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):